Join Growin Stock Community!

Moolec science s.a.MLEC.US Overview

US StockHealthcare
(No presentation for MLEC)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

MLEC AI Insights

MLEC Overall Performance

MLEC AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

MLEC Recent Performance

-19.09%

Moolec science s.a.

0.05%

Avg of Sector

-0.31%

S&P500

MLEC PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

MLEC Key Information

MLEC Financial Forecast

chart

Browsing restrictions can be lifted for a fee.

QuarterlyEPS ForecastQoQMaxMin
2026Q1
2026Q2
2026Q3
2026Q4
2027Q1

MLEC Profile

Moolec Science SA, a science-based ingredient company, focuses on producing animal proteins in plants through Molecular Farming, a disruptive technology in the alternative protein landscape. The company's product portfolio and pipeline leverage the agronomic efficiency of used target crops, such as soybeans and peas. It operates in the United States, Europe, and South America. The company was founded in 2008 and is based in Luxembourg.

Price of MLEC

MLEC FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

MLEC Earnings Table

Unit : USD

QTRNon-GAAP EPSEPS YoYEPS Surprise %SalesSales YoYSales Surprise %NPM
Current
2025Q4
2025Q3
2025Q2
2025Q1
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-12.67
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
0.02
PB Ratio
1.07
Price-to-FCF
-
METRIC
VALUE
vs. INDUSTRY
Gross Margin
-21.17%
Net Margin
-96.96%
Revenue Growth (YoY)
68.63%
Profit Growth (YoY)
-524.97%
3-Year Revenue Growth
-%
3-Year Profit Growth
-%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-12.67
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
0.02
PB Ratio
1.07
Price-to-FCF
-
Gross Margin
-21.17%
Net Margin
-96.96%
Revenue Growth (YoY)
68.63%
Profit Growth (YoY)
-524.97%
3-Year Revenue Growth
-%
3-Year Profit Growth
-%

  • When is MLEC's latest earnings report released?

    The most recent financial report for Moolec science s.a. (MLEC) covers the period of 2025Q4 and was published on 2025/06/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating MLEC's short-term business performance and financial health. For the latest updates on MLEC's earnings releases, visit this page regularly.

  • How much debt does MLEC have?

    As of the end of the reporting period, Moolec science s.a. (MLEC) had total debt of 276.61M, with a debt ratio of 0.36. Short-term debt comprises a higher/lower proportion. The level of financial leverage directly impacts the company's capital structure and interest coverage. If debt is high, pay attention to interest expenses and refinancing risks. Conversely, a low-leverage structure indicates greater risk tolerance but potentially less growth flexibility.

  • How much cash does MLEC have?

    At the end of the period, Moolec science s.a. (MLEC) held Total Cash and Cash Equivalents of 32.7M, accounting for 0.04 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.